BBLG Live signals | Maximize Profits with Getagraph.com

SELL 132642 min ago

@ $4.66

Issued: 9 Feb 2024 @ 15:44

Return: -58.78%

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 16:00):

Stats
Today's Volume	42 507.00
Average Volume	79 535.00
Market Cap	1.69M
EPS	$0 ( 2024-04-04 )
Next earnings date	( $-7.60 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0350 (1.82%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Walsh Deina H	Buy	12 500	Employee Stock Option
2024-01-17	Frelick Jeff	Buy	25 000	Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	8	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	9	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Sell	0	Common Stock

INSIDER POWER
33.11
Last 92 transactions
Buy: 61 072 197 \| Sell: 15 856 455

Bone Biologics Correlation

10 Most Positive Correlations
TRKA	0.919
BIRD	0.904
EBTC	0.903
FLGT	0.902
MAXN	0.901
AFRM	0.896
RRGB	0.893
PWOD	0.891
RDFN	0.89
GP	0.889

10 Most Negative Correlations
FINW	-0.896
ACGL	-0.883
ABST	-0.877
SLAB	-0.871
GXII	-0.871
MSAC	-0.87
EVBG	-0.868
PLMR	-0.865
RGCO	-0.864
KINS	-0.864

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bone Biologics Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-34.01

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-34.01

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$14.62

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.553

Financial Reports:

No articles found.

Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.